| Obesity, Morbid |
Phase 4 |
ClinicalTrials |
| Malabsorption Syndromes |
Phase 4 |
ClinicalTrials |
| Crohn Disease; Malabsorption Syndromes |
Phase 4 |
ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 2 |
Phase 3 |
ClinicalTrials |
| Glucose Intolerance; Insulin Resistance; Prediabetic State |
Phase 3 |
ClinicalTrials |
| Obesity, Morbid |
Phase 4 |
ClinicalTrials |
| Fecal Incontinence; Malabsorption Syndromes |
Phase 3 |
ClinicalTrials |
| Diarrhea; Irritable Bowel Syndrome; Syndrome |
Phase 2 |
ClinicalTrials |
| Diabetes Mellitus, Type 2 |
Phase 4 |
ClinicalTrials |
| Diarrhea; Multiple Myeloma; Neoplasms, Plasma Cell |
Phase 2 |
ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 2 |
Phase 2 |
ClinicalTrials |
| Dyslipidemias; Hyperglycemia; Hyperlipidemias; Hyperlipoproteinemias |
Phase 4 |
ClinicalTrials |
| Liver Diseases; Pruritus |
Phase 2/Phase 3 |
ClinicalTrials |
| Diabetes Mellitus, Type 2 |
Phase 4 |
ClinicalTrials |
| Diarrhea; Irritable Bowel Syndrome; Malabsorption Syndromes |
Phase 2 |
ClinicalTrials |
| Diarrhea; Irritable Bowel Syndrome; Syndrome |
Phase 4 |
ClinicalTrials |
| Atherosclerosis; Carotid Artery Diseases; Coronary Artery Disease |
Phase 4 |
ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Intolerance; Hypercholesterolemia; Prediabetic State |
Phase 3 |
ClinicalTrials |